Multifunctional antimicrobial peptides: therapeutic targets in several human diseases
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829 · cited 1×
“Antimicrobial peptides (AMPs), also known as genetically encoded antibiotic peptides, are conserved components of the innate immune response [1, 2].”
BackgroundChemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180 · cited 3×
“How AMPs inhibit viral entry into cells? HIV entry into a target cell is facilitated by its gp120/gp41 glycoprotein (env) interaction with CD14 [51] and a coreceptor, usually CCR5 or CXCR4 [52].”
BackgroundEndogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Anti-microbial peptides: from invertebrates to vertebrates
Bulet, P., Stöcklin, R., & Menin, L. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0124.x · Cited by 1,107 · cited 1×
“They are produced in many organisms including bacteria, insects, plants, and vertebrates, where they represent a defense system [3–5].”
BackgroundMammalian defensins in immunity: more than just microbicidal
Yang, D., Biragyn, A., Kwak, L. W., & Oppenheim, J. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02246-9 · Cited by 696
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E., & Schröder, J.-M. (2005) · Nature Immunology · doi:10.1038/ni1142 · Cited by 651 · cited 1×
“Study of psoriatic-scale extracts revealed the presence of several AMPs including LL-37, human neutrophil defensin 1-3, RNase 7, and lysozyme (reviewed in [71, 72]).”
BackgroundHeilborn, J. D., Nilsson, M. F., Sørensen, O., Ståhle-Bäckdahl, M., Kratz, G., Weber, G., & Borregaard, N. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12069.x · Cited by 572
Dorschner, R. A., Pestonjamasp, V. K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G. H., & Gallo, R. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01340.x · Cited by 567
Cited by
The Alzheimer's Disease-Associated Amyloid β-Protein Is an Antimicrobial Peptide
Soscia, S. J., Kirby, J. E., Washicosky, K. J., Tucker, S. M., Ingelsson, M., Hyman, B., Burton, M. A., Goldstein, L. E., Duong, S., Tanzi, R. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009505 · Cited by 1,060
“AMPs are also potent immunomodulators that mediate cytokine release and adaptive immune responses (see review by Zaiou, 2007 [8]).”
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
The role of astrocytes in amyloid production and Alzheimer's disease
Frost, G. R., & Li, Y.-M. (2017) · Open Biology · doi:10.1098/rsob.170228 · Cited by 435
The therapeutic applications of antimicrobial peptides (AMPs): a patent review
Kang, H.-K., Kim, C., Seo, C. H., & Park, Y. (2017) · Journal of Microbiology · doi:10.1007/s12275-017-6452-1 · Cited by 386
Anionic Antimicrobial Peptides from Eukaryotic Organisms
Harris, F., Dennison, S., & Phoenix, D. (2009) · Current Protein & Peptide Science · doi:10.2174/138920309789630589 · Cited by 332
Park, S.-C., Park, Y., & Hahm, K.-S. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095971 · Cited by 327
Parisien, A., Allain, B., Zhang, J., Mandeville, R., & Lan, C. Q. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03498.x · Cited by 300
Antimicrobial peptides and bacteriocins: alternatives to traditional antibiotics
Sang, Y., & Blecha, F. (2008) · Animal Health Research Reviews · doi:10.1017/s1466252308001497 · Cited by 254
Transmembrane Pores Formed by Human Antimicrobial Peptide LL-37
Lee, C.-C., Sun, Y., Qian, S., & Huang, H. W. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.02.018 · Cited by 202
Porphyromonas gingivalis Periodontal Infection and Its Putative Links with Alzheimer’s Disease
Singhrao, S. K., Harding, A., Poole, S., Kesavalu, L., & Crean, S. (2015) · Mediators of Inflammation · doi:10.1155/2015/137357 · Cited by 195
“It is therefore not surprising that Aβ functions are related to innate immune defence mechanisms that mediate intrinsic responses [109].”
BackgroundThe chemistry and biology of LL-37
Burton, M. F., & Steel, P. G. (2009) · Natural Product Reports · doi:10.1039/b912533g · Cited by 173
Spitzer, P., Condic, M., Herrmann, M., Oberstein, T. J., Scharin-Mehlmann, M., Gilbert, D. F., Friedrich, O., Grömer, T., Kornhuber, J., Lang, R., et al. (2016) · Scientific Reports · doi:10.1038/srep32228 · Cited by 128
Metadata
- Authors
- Zaiou, M.
- Venue
- Journal of Molecular Medicine
- Published
- 2007-01-10
- Volume
- 85
- Issue
- 4
- Pages
- 317-329
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W1978317025
- Cited by
- 236
- References
- 12
- FWCI
- 17.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.